Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Saved in:
| Title: | Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. |
|---|---|
| Authors: | Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Meyerhoff C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Nelde A; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Kandabarau S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Büttner F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. |
| Source: | Genome medicine [Genome Med] 2020 Mar 30; Vol. 12 (1), pp. 32. Date of Electronic Publication: 2020 Mar 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32228647 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reustle+A%22">Reustle A</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Di+Marco+M%22">Di Marco M</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Meyerhoff+C%22">Meyerhoff C</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Nelde+A%22">Nelde A</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Walz+JS%22">Walz JS</searchLink>; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Winter+S%22">Winter S</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kandabarau+S%22">Kandabarau S</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Büttner+F%22">Büttner F</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Haag+M%22">Haag M</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Backert+L%22">Backert L</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kowalewski+DJ%22">Kowalewski DJ</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rausch+S%22">Rausch S</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hennenlotter+J%22">Hennenlotter J</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stühler+V%22">Stühler V</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scharpf+M%22">Scharpf M</searchLink>; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Fend+F%22">Fend F</searchLink>; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stenzl+A%22">Stenzl A</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rammensee+HG%22">Rammensee HG</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bedke+J%22">Bedke J</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stevanović+S%22">Stevanović S</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schwab+M%22">Schwab M</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.<br /><searchLink fieldCode="AU" term="%22Schaeffeler+E%22">Schaeffeler E</searchLink>; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101475844%22">Genome medicine</searchLink> [Genome Med] 2020 Mar 30; Vol. 12 (1), pp. 32. <i>Date of Electronic Publication: </i>2020 Mar 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101475844 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-994X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756994X%22">1756994X </searchLink><i>NLM ISO Abbreviation: </i>Genome Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32228647 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13073-020-00731-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 32 Titles: – TitleFull: Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reustle A – PersonEntity: Name: NameFull: Di Marco M – PersonEntity: Name: NameFull: Meyerhoff C – PersonEntity: Name: NameFull: Nelde A – PersonEntity: Name: NameFull: Walz JS – PersonEntity: Name: NameFull: Winter S – PersonEntity: Name: NameFull: Kandabarau S – PersonEntity: Name: NameFull: Büttner F – PersonEntity: Name: NameFull: Haag M – PersonEntity: Name: NameFull: Backert L – PersonEntity: Name: NameFull: Kowalewski DJ – PersonEntity: Name: NameFull: Rausch S – PersonEntity: Name: NameFull: Hennenlotter J – PersonEntity: Name: NameFull: Stühler V – PersonEntity: Name: NameFull: Scharpf M – PersonEntity: Name: NameFull: Fend F – PersonEntity: Name: NameFull: Stenzl A – PersonEntity: Name: NameFull: Rammensee HG – PersonEntity: Name: NameFull: Bedke J – PersonEntity: Name: NameFull: Stevanović S – PersonEntity: Name: NameFull: Schwab M – PersonEntity: Name: NameFull: Schaeffeler E IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 03 Text: 2020 Mar 30 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1756-994X Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Genome medicine Type: main |
| ResultId | 1 |